Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 7, 2014
Effects of stress reduction on cardiovascular risk factors in type 2 diabetes patients with early kidney disease - results of a randomized controlled trial (HEIDIS)S Kopf, D Oikonomou, M Hartmann, et al.
Clinical Endocrinology|September 10, 2008
Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetesM von Eynatten, D Liu, A Bluemm, et al.
Journal of Internal Medicine|March 3, 2011
HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarctionM Andrassy, H C Volz, N Riedle, et al.
Diabetes Care|May 20, 1998
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDMM A Hofmann, B Kohl, M S Zumbach, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 12, 2007
Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activityG Rudofsky, P Reismann, I A Grafe, et al.
Diabetes, Obesity & Metabolism|June 11, 2003
Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa BS Schiekofer, G Rudofsky, M Andrassy, et al.
Pageof 9